GlassScriptPhysician profile
Beverly A Driskill
NPI 1689762122
$1,791.48
in general payments reported to CMS, 2019-2025
14 companies · $655 in 2025
The $655 reported for 2025 was more than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $207 · 2023: $849 · 2024: $79.74 · 2025: $655.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,584.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,584.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurocrine Biosciences, INC. | $320.08 | 2022-2025 | Ingrezza |
| Alkermes, INC. | $249.87 | 2022-2025 | Aristada, Lybalvi |
| Supernus Pharmaceuticals, INC. | $237.77 | 2023-2025 | Qelbree, Qelbree |
| Otsuka America Pharmaceutical, INC. | $233.64 | 2023-2025 | Rexulti, Abilify Asimtufii, Abilify Maintena |
| E.R. Squibb & Sons, L.L.C. | $210.66 | 2025 | Cobenfy |
| Abbvie INC. | $114.82 | 2023-2025 | |
| Janssen Pharmaceuticals, INC | $89.09 | 2023-2025 | Spravato, Invega Sustenna |
| Teva Pharmaceuticals USA, INC. | $88.03 | 2023-2025 | Uzedy, Austedo Xr |
| Takeda Pharmaceuticals U.S.A., INC. | $76.94 | 2023 | Trintellix |
| Axsome Therapeutics, INC. | $48.73 | 2023-2025 | Auvelity |
| Corium, LLC | $34.40 | 2023 | Azstarys |
| Idorsia Pharmaceuticals US INC | $31.10 | 2023 | Quviviq |
| Lundbeck LLC | $29.72 | 2023-2025 | Rexulti |
| Merck Sharp & Dohme LLC | $26.63 | 2023 | Belsomra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Beverly Driskill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.